BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38023714)

  • 1. Enhancement of the therapeutic efficacy of the MAP regimen using thiamine pyrophosphate-decorated albumin nanoclusters in osteosarcoma treatment.
    Yoo SY; Mun YH; Kang NW; Koo JM; Lee DH; Yoo JH; Lee SM; Koh S; Park JC; Kim T; Shin EK; Lee HS; Sim J; Kang KW; Kim SK; Cho CW; Kim MG; Kim DD; Lee JY
    Bioeng Transl Med; 2023 Nov; 8(6):e10472. PubMed ID: 38023714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyapatite-binding albumin nanoclusters for enhancing bone tumor chemotherapy.
    Kang NW; Lee JY; Kim DD
    J Control Release; 2022 Feb; 342():111-121. PubMed ID: 34990700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery.
    Wu S; Yang X; Luo F; Wu T; Xu P; Zou M; Yan J
    J Nanobiotechnology; 2018 Nov; 16(1):90. PubMed ID: 30424776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.
    Burger AM; Hartung G; Stehle G; Sinn H; Fiebig HH
    Int J Cancer; 2001 Jun; 92(5):718-24. PubMed ID: 11340578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity.
    Polat B; Suleyman H; Sener E; Akcay F
    J Cardiovasc Pharmacol Ther; 2015 Mar; 20(2):221-9. PubMed ID: 25316705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion effects of curcumin on multidrug resistance of MNNG/HOS human osteosarcoma cells in vitro and in vivo through regulation of P-glycoprotein.
    Si M; Zhao J; Li X; Tian JG; Li YG; Li JM
    Chin Med J (Engl); 2013 Nov; 126(21):4116-23. PubMed ID: 24229684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
    Choeyprasert W; Pakakasama S; Sirachainan N; Songdej D; Chuansumrit A; Anurathapan U; Hongeng S; Nartthanarung A
    Asian Pac J Cancer Prev; 2014; 15(22):9823-9. PubMed ID: 25520112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
    Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
    Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized Co-delivery of Doxorubicin, Cisplatin, and Methotrexate by Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
    Ma H; He C; Cheng Y; Yang Z; Zang J; Liu J; Chen X
    ACS Appl Mater Interfaces; 2015 Dec; 7(49):27040-8. PubMed ID: 26575336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of biotin targeted methotrexate-human serum albumin conjugated nanoparticles to enhance methotrexate antitumor efficacy.
    Taheri A; Dinarvand R; Nouri FS; Khorramizadeh MR; Borougeni AT; Mansoori P; Atyabi F
    Int J Nanomedicine; 2011; 6():1863-74. PubMed ID: 21931482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IAP Chemotherapy Regimen Is a Viable and Cost-effective Option in Children and Adolescents With Osteosarcoma: A Comparative Analysis With MAP Regimen on Toxicity and Survival.
    Verma P; Jain S; Kapoor G; Tripathi R; Sharma P; Doval DC
    J Pediatr Hematol Oncol; 2021 May; 43(4):e466-e471. PubMed ID: 32925402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells.
    Taheri A; Dinarvand R; Atyabi F; Ghahremani MH; Ostad SN
    Eur J Pharm Sci; 2012 Sep; 47(2):331-40. PubMed ID: 22771547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process
    Kang NW; Visetvichaporn V; Nguyen DT; Shin EK; Kim D; Kim MJ; Yoo SY; Lee JY; Kim DD
    Mater Today Bio; 2023 Apr; 19():100591. PubMed ID: 36873733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxorubicin derivative loaded acetal-PEG-PCCL micelles for overcoming multidrug resistance in MCF-7/ADR cells.
    Zhong XC; Xu WH; Wang ZT; Guo WW; Chen JJ; Guo NN; Wang TT; Lin MT; Zhang ZT; Lu YY; Yang QY; Han M; Xu DH; Gao JQ
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1556-1564. PubMed ID: 31271317
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
    Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
    Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor.
    Prakash J; Beljaars L; Harapanahalli AK; Zeinstra-Smith M; de Jager-Krikken A; Hessing M; Steen H; Poelstra K
    Int J Cancer; 2010 Apr; 126(8):1966-1981. PubMed ID: 19795464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondria-targeted zirconium metal-organic frameworks for enhancing the efficacy of microwave thermal therapy against tumors.
    Zhou H; Fu C; Chen X; Tan L; Yu J; Wu Q; Su L; Huang Z; Cao F; Ren X; Ren J; Liang P; Meng X
    Biomater Sci; 2018 May; 6(6):1535-1545. PubMed ID: 29670952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.